As technologies powered by Artificial Intelligence (AI) continue to push new boundaries and see ever-deeper integration with existing sectors. Healthtech in particular is already seeing remarkable new developments that stand to transform the sector as we know it.
According to a report from Rock Health, venture funding for digital health companies hit $10.1 billion across 497 deals in the US alone in 2024. Investment in AI-enabled health startups made up 37% of the year’s overall funding, demonstrating the sheer volume of investor interest in AI-driven technology in the sector.
Anar Murtuzayev, CEO of Mount Venture Capital Fund – a private investment firm with a diverse portfolio, including Healthtech, provides expert insights on the implications of AI for the sector, what investors should expect to see over the next twelve months, and some of the exciting new technologies in development that are expected to be game changers.
TFN: AI is transforming healthcare at an unprecedented pace. What specific advancements in AI-driven precision medicine and mental health tech do you see making the biggest impact in 2025?
Anar Murtuzayev: AI-driven precision medicine is set to change the game by tailoring treatments to individual patients based on their genetics, lifestyle, and environment – no more one-size-fits-all approaches. This means quicker, more effective care, especially for those with tricky or treatment-resistant conditions.
On the mental health side, AI is stepping up with tools that detect patterns in brain activity, helping doctors pinpoint the right treatment faster. We’re also seeing AI-powered virtual therapists and chatbots becoming smarter, offering real-time support for people struggling with anxiety, depression, and burnout.
TFN: With the rise of Telehealth 2.0 and remote patient monitoring, how are investors balancing the need for innovation with concerns around data security and compliance?
AM: Investors see security and compliance not just as regulatory hurdles but as competitive advantages. Startups that integrate privacy-first design and transparent data practices from the outset are more likely to gain trust from both users and enterprise clients.
Increasingly, the focus is shifting from reactive compliance to proactive risk management – companies that can anticipate regulatory changes and build adaptable security frameworks will have an edge. In sectors like remote monitoring, where sensitive data flows constantly, the ability to ensure integrity and privacy isn’t just a requirement – it’s a key differentiator in the market.
TFN: Startups working on decentralised clinical trials and blockchain for healthcare are gaining traction. What role do you see these technologies playing in improving patient outcomes and streamlining the industry?
AM: Decentralised clinical trials are a massive win for medical research. By using wearables and remote monitoring, they let more diverse groups of patients take part as there’s no need to travel miles for check-ups. This means more inclusive, accurate results and faster drug development.
Blockchain is also making a splash by securing patient records, preventing fraud, and making consent processes smoother. Together, these technologies are cutting red tape, improving trust, and speeding up access to life-changing treatments.
TFN: The U.S. healthcare system is notoriously complex. How do you think the upcoming policy reforms under the new administration will affect HealthTech startups and investment trends?
AM: If the new administration follows through on its proposed reforms, we could see a serious boost for HealthTech. Faster FDA approvals for AI-powered diagnostics mean life-saving tech reaches patients quicker. Standardising health data rules would take the headache out of compliance for startups, letting them focus on innovation instead.
At the same time, the administration’s stance on federal healthcare spending and insurance regulations may introduce both challenges and openings for innovation. If reimbursement policies for digital health and remote care continue to evolve, startups in these spaces could benefit from increased adoption.
TFN: Mount VC has backed some of the most innovative startups in digital health. What qualities do you look for in HealthTech founders, and what advice would you give to startups looking to secure funding in this space?
AM: We look for founders who have a deep understanding of both the healthcare system and the complexities of scaling a digital health business. The best teams not only develop innovative solutions but also know how to navigate regulatory hurdles, integrate with existing healthcare infrastructure, and build sustainable revenue models.
Our advice? Show that you understand the path to commercialization, have a clear go-to-market strategy, and can demonstrate measurable outcomes. Strong industry partnerships and seamless integrations into existing healthcare workflows will also be key differentiators in this increasingly competitive space.
Anar Murtuzayev is CEO of Mount Venture Capital Fund LP, a private investment firm specialising in early-stage Healthtech and Fintech startups. You can find out more about the fund’s investment strategy and the companies it backs on its website.
This article is part of a media partnership with Mount Venture Capital.
